Climatic is building a new consumer category around proactive, everyday lung care. Grounded in more than three years of research led by Chief Science Officer Dr. Dale Christensen of Duke University Medical Center, the company’s first product is L Max, a daily lung health system slated to launch in late spring 2026. In pre-clinical studies, a single dose of L Max improved mucus clearance by over 50% within minutes, with effects lasting eight hours, and the result has been replicated in more than ten independent tests. A five-week user study with endurance athletes showed 98% reporting easier breathing and an average 6% improvement in time trials, while 80% saw better heart-rate variability; a larger randomized, placebo-controlled clinical trial is underway. Co-founded by CEO Eric Kau (former Seed Health COO) and CCO Allie Melnick (former Harry’s executive), Climatic has assembled advisors from Mayo Clinic, elite athletics, and leading consumer brands. The company plans to expand its portfolio into additional products addressing environmental health stressors. Climatic’s $10 million seed financing provides the capital to accelerate research, grow the team, and prepare for product launch.

Total raised

$10M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2026